142 related articles for article (PubMed ID: 16322235)
1. Platelet-derived growth factor-induced p42/44 mitogen-activated protein kinase activation and cellular growth is mediated by reactive oxygen species in the absence of TSC2/tuberin.
Finlay GA; Thannickal VJ; Fanburg BL; Kwiatkowski DJ
Cancer Res; 2005 Dec; 65(23):10881-90. PubMed ID: 16322235
[TBL] [Abstract][Full Text] [Related]
2. The positive feedback role of arachidonic acid in the platelet-derived growth factor-induced signaling in lens epithelial cells.
Zhang W; Wang Y; Chen CW; Xing K; Vivekanandan S; Lou MF
Mol Vis; 2006 Jul; 12():821-31. PubMed ID: 16902399
[TBL] [Abstract][Full Text] [Related]
3. Extracellular cysteine/cystine redox regulates the p44/p42 MAPK pathway by metalloproteinase-dependent epidermal growth factor receptor signaling.
Nkabyo YS; Go YM; Ziegler TR; Jones DP
Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G70-8. PubMed ID: 15746213
[TBL] [Abstract][Full Text] [Related]
4. Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival.
Ghosh S; Tergaonkar V; Rothlin CV; Correa RG; Bottero V; Bist P; Verma IM; Hunter T
Cancer Cell; 2006 Sep; 10(3):215-26. PubMed ID: 16959613
[TBL] [Abstract][Full Text] [Related]
5. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
Astrinidis A; Henske EP
Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294
[TBL] [Abstract][Full Text] [Related]
6. Akt regulates nuclear/cytoplasmic localization of tuberin.
Rosner M; Freilinger A; Hengstschläger M
Oncogene; 2007 Jan; 26(4):521-31. PubMed ID: 16862180
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus inhibits platelet-derived growth factor-induced collagen synthesis in rat vascular smooth muscle cells.
Park J; Ha H; Ahn HJ; Kang SW; Kim YS; Seo JY; Kim MS
Transplant Proc; 2005 Oct; 37(8):3459-62. PubMed ID: 16298629
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions.
Kaper F; Dornhoefer N; Giaccia AJ
Cancer Res; 2006 Feb; 66(3):1561-9. PubMed ID: 16452213
[TBL] [Abstract][Full Text] [Related]
9. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors.
Kenerson HL; Aicher LD; True LD; Yeung RS
Cancer Res; 2002 Oct; 62(20):5645-50. PubMed ID: 12384518
[TBL] [Abstract][Full Text] [Related]
10. HaRas activates the NADPH oxidase complex in human neuroblastoma cells via extracellular signal-regulated kinase 1/2 pathway.
Serù R; Mondola P; Damiano S; Svegliati S; Agnese S; Avvedimento EV; Santillo M
J Neurochem; 2004 Nov; 91(3):613-22. PubMed ID: 15485492
[TBL] [Abstract][Full Text] [Related]
11. Platelet derived growth factor (PDGF)-induced reactive oxygen species in the lens epithelial cells: the redox signaling.
Chen KC; Zhou Y; Xing K; Krysan K; Lou MF
Exp Eye Res; 2004 Jun; 78(6):1057-67. PubMed ID: 15109912
[TBL] [Abstract][Full Text] [Related]
12. Tuberous sclerosis-associated neoplasms express activated p42/44 mitogen-activated protein (MAP) kinase, and inhibition of MAP kinase signaling results in decreased in vivo tumor growth.
Govindarajan B; Mizesko MC; Miller MS; Onda H; Nunnelley M; Casper K; Brat D; Cohen C; Arbiser JL
Clin Cancer Res; 2003 Aug; 9(9):3469-75. PubMed ID: 12960139
[TBL] [Abstract][Full Text] [Related]
13. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
14. Contribution of phospholipase D in endothelin-1-mediated extracellular signal-regulated kinase activation and proliferation in rat uterine leiomyoma cells.
Robin P; Chouayekh S; Bole-Feysot C; Leiber D; Tanfin Z
Biol Reprod; 2005 Jan; 72(1):69-77. PubMed ID: 15355882
[TBL] [Abstract][Full Text] [Related]
15. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.
Kwiatkowski DJ; Manning BD
Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R251-8. PubMed ID: 16244323
[TBL] [Abstract][Full Text] [Related]
16. The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.
Nobukini T; Thomas G
Novartis Found Symp; 2004; 262():148-54; discussion 154-9, 265-8. PubMed ID: 15562827
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells.
Hsieh HL; Wu CB; Sun CC; Liao CH; Lau YT; Yang CM
J Cell Physiol; 2006 Jun; 207(3):757-66. PubMed ID: 16508949
[TBL] [Abstract][Full Text] [Related]
18. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.
Roux PP; Ballif BA; Anjum R; Gygi SP; Blenis J
Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13489-94. PubMed ID: 15342917
[TBL] [Abstract][Full Text] [Related]
19. The role of tuberin in cellular differentiation: are B-Raf and MAPK involved?
Karbowniczek M; Henske EP
Ann N Y Acad Sci; 2005 Nov; 1059():168-73. PubMed ID: 16382052
[TBL] [Abstract][Full Text] [Related]
20. Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner.
Astrinidis A; Senapedis W; Henske EP
Hum Mol Genet; 2006 Jan; 15(2):287-97. PubMed ID: 16339216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
